Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of high cholesterol in age-related COVID19 lethality
Hao Wang, Zixuan Yuan, Mahmud Arif Pavel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 140

Showing 26-50 of 140 citing articles:

SARS‐CoV‐2 induced HDL dysfunction may affect the host's response to and recovery from COVID‐19
Hayder M. Al‐kuraishy, Nawar Raad Hussien, Marwa S. Al‐Niemi, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 20
Alzheimer’s disease and COVID-19: Interactions, intrinsic linkages, and the role of immunoinflammatory responses in this process
Wei Li, Lin Sun, Ling Yue, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Cholesterol Metabolism—Impacts on SARS-CoV-2 Infection Prognosis
Yumeng Peng, Luming Wan, Fan Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 45
Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm
Mattia Vinciguerra, Silvia Romiti, Khalil Fattouch, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 7, pp. 2095-2095
Open Access | Times Cited: 44
Roles of Membrane Domains in Integrin-Mediated Cell Adhesion
Daniel Lietha, Tina Izard
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5531-5531
Open Access | Times Cited: 43
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor
Murat Öz, Dietrich E. Lorke, Nadine Kabbani
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107750-107750
Open Access | Times Cited: 41
COVID-19 enters the expanding network of apolipoprotein E4-related pathologies
Kalliopi Gkouskou, Theodora Vasilogiannakopoulou, Evangelos Andreakos, et al.
Redox Biology (2021) Vol. 41, pp. 101938-101938
Open Access | Times Cited: 39
Follow-up study on serum cholesterol profiles and potential sequelae in recovered COVID-19 patients
Guiling Li, Li Du, Xiaoling Cao, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 34
Glycyrrhizic Acid: A Natural Plant Ingredient as a Drug Candidate to Treat COVID-19
Zhong Sun, Guozhong He, Ninghao Huang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 33
Cell surface detection of vimentin, ACE2 and SARS-CoV-2 Spike proteins reveals selective colocalization at primary cilia
Vasiliki Lalioti, Silvia González-Sanz, Irene Lois-Bermejo, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 25
Angiotensin‐converting enzyme 2 rs2285666 polymorphism and clinical parameters as the determinants of COVID‐19 severity in Iranian population
Fereshteh Khalilzadeh, Fatemeh Sakhaee, Fattah Sotoodehnejadnematalahi, et al.
International Journal of Immunogenetics (2022) Vol. 49, Iss. 5, pp. 325-332
Open Access | Times Cited: 25
Can SARS-CoV-2 Infection Exacerbate Alzheimer’s Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms
Chiara Villa, Eleonora Rivellini, Marialuisa Lavitrano, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 1, pp. 29-29
Open Access | Times Cited: 22
Veklury® (remdesivir) formulations inhibit initial membrane‐coupled events of SARS‐CoV‐2 infection due to their sulfobutylether‐β‐cyclodextrin content
Tamás Kovács, Kitti Kurtan, Zoltán Varga, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 16, pp. 2064-2084
Open Access | Times Cited: 12
Plasma Protein Biomarkers Distinguish Multisystem Inflammatory Syndrome in Children From Other Pediatric Infectious and Inflammatory Diseases
Sophya Yeoh, Diego Estrada‐Rivadeneyra, Heather Jackson, et al.
The Pediatric Infectious Disease Journal (2024) Vol. 43, Iss. 5, pp. 444-453
Open Access | Times Cited: 4
Interaction of drugs with lipid raft membrane domains as a possible target
Hironori Tsuchiya, Maki Mizogami
Drug Target Insights (2020) Vol. 14, Iss. 1, pp. 34-47
Open Access | Times Cited: 34
Possible mechanisms of cholesterol elevation aggravating COVID-19
Yan Tang, Longtai Hu, Yi Liu, et al.
International Journal of Medical Sciences (2021) Vol. 18, Iss. 15, pp. 3533-3543
Open Access | Times Cited: 31
Good Cholesterol Gone Bad? HDL and COVID-19
George Eduardo Gabriel Kluck, Jeong‐Ah Yoo, Emmanuel H. Sakarya, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10182-10182
Open Access | Times Cited: 30
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Laure‐Alix Clerbaux, Maria Cristina Albertini, Núria Amigó, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4464-4464
Open Access | Times Cited: 21
The Influence of SARS-CoV-2 Infection on Lipid Metabolism—The Potential Use of Lipid-Lowering Agents in COVID-19 Management
Klaudia Kowalska, Zofia Sabatowska, Joanna Forycka, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2320-2320
Open Access | Times Cited: 21
A critical evaluation of risk to reward ratio of quercetin supplementation for COVID‐19 and associated comorbid conditions
Anil Pawar, Maria Russo, Isha Rani, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 6, pp. 2394-2415
Open Access | Times Cited: 20
COVID‐19 and the impact on Alzheimer's disease pathology
Susana Furman, Kim N. Green, Thomas E. Lane
Journal of Neurochemistry (2023)
Open Access | Times Cited: 10
Role of lipoprotein structure and dynamics in disease development: from atherosclerosis to Covid-19
Correa Marcano Yubexi Yakari
(2023)
Open Access | Times Cited: 10
Obesity and COVID‐19: A jigsaw puzzle with still missing pieces
Konstantinos Michalakis, Grigorios Panagiotou, Ιoannis Ilias, et al.
Clinical Obesity (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19
Gourab Das, Troyee Das, Nilkanta Chowdhury, et al.
Genomics (2020) Vol. 113, Iss. 1, pp. 1129-1140
Open Access | Times Cited: 27
Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities
Tiantian Yan, Rong Xiao, Nannan Wang, et al.
Theranostics (2021) Vol. 11, Iss. 17, pp. 8234-8253
Open Access | Times Cited: 24

Scroll to top